Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000912282-15-000245
Filing Date
2015-07-17
Accepted
2015-07-16 17:57:37
Documents
9
Effectiveness Date
2015-07-17

Document Format Files

Seq Description Document Type Size
1 oncolyticss8_071515.htm S-8 90743
2 INCENTIVE SHARE AWARD PLAN ex4_2.htm EX-4.2 142138
3 OPINION OF MCCARTHY T?TRAULT LLP ex5_1.htm EX-5.1 17440
4 CONSENT OF ERNST & YOUNG LLP ex23_1.htm EX-23.1 1904
5 oncolyticslogo_shareaward.jpg GRAPHIC 12945
6 mccarthylogo_p1.jpg GRAPHIC 15960
7 mccarthylogo_p2.jpg GRAPHIC 8740
8 oncolytics_logo.jpg GRAPHIC 10103
9 oncolytics_ex23.jpg GRAPHIC 95697
  Complete submission text file 0000912282-15-000245.txt   451544
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-205708 | Film No.: 15992269
SIC: 2834 Pharmaceutical Preparations